| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.38B | 29.56B | 26.83B | 22.53B | 21.90B | 19.38B |
| Gross Profit | 10.55B | 10.97B | 8.77B | 5.44B | 3.85B | 4.04B |
| EBITDA | 1.01B | 3.23B | 1.19B | -1.67B | -3.82B | -3.95B |
| Net Income | 220.34M | 1.16B | -1.35B | -4.82B | -7.51B | -6.81B |
Balance Sheet | ||||||
| Total Assets | 38.79B | 41.19B | 32.70B | 33.16B | 41.83B | 52.05B |
| Cash, Cash Equivalents and Short-Term Investments | 22.29B | 24.21B | 16.54B | 15.04B | 19.56B | 30.22B |
| Total Debt | 9.82B | 9.64B | 5.15B | 7.64B | 15.54B | 19.22B |
| Total Liabilities | 24.64B | 25.63B | 18.59B | 18.75B | 26.59B | 30.34B |
| Stockholders Equity | 14.16B | 15.58B | 14.11B | 14.39B | 15.24B | 21.70B |
Cash Flow | ||||||
| Free Cash Flow | 3.29B | 5.32B | 4.26B | -1.06B | -6.65B | -6.33B |
| Operating Cash Flow | 3.29B | 7.15B | 6.01B | 266.62M | -3.91B | -2.65B |
| Investing Cash Flow | -7.19B | -9.34B | -138.09M | 1.76B | 10.61B | -24.58B |
| Financing Cash Flow | 4.30B | 4.09B | -2.83B | -5.07B | -4.35B | 30.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$3.53B | 7.47 | 17.91% | 3.82% | -4.19% | 0.41% | |
73 Outperform | HK$536.27B | 18.22 | 22.14% | 2.22% | 6.96% | 14.02% | |
69 Neutral | HK$31.84B | 18.73 | 44.75% | 1.18% | 14.94% | 84.38% | |
67 Neutral | HK$33.37B | 17.96 | 8.02% | 0.48% | -6.10% | 25.65% | |
66 Neutral | HK$71.33B | 35.85 | 8.04% | ― | 13.20% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
39 Underperform | HK$887.69M | -21.27 | -27.26% | ― | -11.59% | ― |